Seeking Alpha

Premiums are rising on healthcare deals, as drug companies scramble to secure a narrowing field...

Premiums are rising on healthcare deals, as drug companies scramble to secure a narrowing field of companies with viable prospects. There's a "panicky quality to deals" now, says one I-banker, and premiums may be forced even higher as competition among buyers intensifies.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs